Kaitoukov Youri, Soulez Gilles, Oliva Vincent L, Giroux Marie-France, Bourdeau Isabelle, Lacroix André, Gilbert Patrick, Therasse Eric
Division of Interventional Radiology, Department of Radiology, Centre Hospitalier de l'Université de Montréal (CHUM), 3840 Saint-Urbain St, Montréal, QC, H2W 1T8, Canada,
Cardiovasc Intervent Radiol. 2014 Jun;37(3):795-9. doi: 10.1007/s00270-013-0794-9. Epub 2013 Dec 11.
Many adrenal venous sampling (AVS) protocols require repeated samplings before and after adrenocorticotrophic hormone (ACTH) stimulation. Maintaining catheter selectivity in the adrenal vein over time is essential but can be challenging, especially in the short right adrenal vein, where the catheter is often in an unstable position. The aim of our study was to evaluate guide wire insertion into the right adrenal vein catheter to sustain AVS selectivity (adrenal/peripheral cortisol ratio [Ca/Cp]) over time.
This retrospective investigation was approved by our institutional review board, and informed consent was obtained. A 0.014-inch guide wire was inserted in the right adrenal vein 5F catheter to secure its positioning and to facilitate blood sampling. Plasma cortisol levels from the left and right adrenal veins and left iliac vein were assessed in 117 consecutive patients undergoing bilateral, simultaneous sets of AVS at -5 and 0 min (baseline) and 5, 10, and 15 min after intravenous bolus of 250 μg ACTH (stimulated). Ca/Cp ratios of ≥2 for baseline and >10 for stimulated AVS were considered selective.
The first sampling, at time -5 min, was nonselective in 41 of 116 (35.3 %) right and 30 of 116 (25.9 %) left AVSs retained for analysis. In patients with a selective first sampling, 74 of 75 (98.7 %) right and 85 of 86 (98.8 %) left AVSs were selective in all post-ACTH samplings. Right and left selectivity rates were not statistically different (p > 0.87). No complications arose from guide wire insertion.
Guide wire insertion into the right adrenal vein catheter is safe and effective to maintain AVS selectivity over time.
许多肾上腺静脉采血(AVS)方案要求在促肾上腺皮质激素(ACTH)刺激前后进行重复采血。随着时间的推移,维持肾上腺静脉导管的选择性至关重要,但可能具有挑战性,尤其是在右侧肾上腺短静脉中,导管位置往往不稳定。我们研究的目的是评估将导丝插入右侧肾上腺静脉导管以维持AVS选择性(肾上腺/外周皮质醇比值[Ca/Cp])随时间的变化。
这项回顾性研究经我们机构审查委员会批准,并获得了知情同意。将一根0.014英寸的导丝插入右侧肾上腺静脉5F导管中,以确保其定位并便于采血。在117例连续接受双侧同时AVS的患者中,分别在-5分钟和0分钟(基线)以及静脉推注250μg ACTH后5、10和15分钟(刺激后)评估左、右肾上腺静脉和左髂静脉的血浆皮质醇水平。基线时Ca/Cp比值≥2且刺激后AVS时>10被认为具有选择性。
在保留用于分析的116例右侧AVS中,41例(35.3%)在-5分钟时的首次采血是非选择性的;在116例左侧AVS中,30例(25.9%)是非选择性的。在首次采血具有选择性的患者中,75例右侧AVS中的74例(98.7%)和86例左侧AVS中的85例(98.8%)在所有ACTH刺激后的采血中均具有选择性。左右选择性率无统计学差异(p>0.87)。导丝插入未引起并发症。
将导丝插入右侧肾上腺静脉导管对维持AVS选择性随时间变化是安全有效的。